About
This forum is an educational website developed under the auspices of the University of Glasgow and is dedicated to the dissemination of the latest developments in cytokine signalling. It provides continuing medical education to clinicians around the globe to facilitate greater understanding of the science of cytokines and cytokine signalling, and its implications for clinical practice.
The programmes are free from commercial bias, and feature leading experts sharing their knowledge and experience in the form of video tutorials.
Podcasts
Discussing PsA: 2023 EULAR recommendations and improvements in PROs with deucravacitinib
Podcasts
Discussing AxSpA: Long-term etanercept response and real-world effectiveness of tofacitinib and adalimumab
Podcasts
Discussing RA: April 2024
Podcasts
Author Interview: Professor Maria Antonietta D’Agostino, 2024
Podcasts
Author Interview: Professor Dennis McGonagle, 2024
Podcasts
Discussing AxSpA: Secukinumab retention over time & sacroiliac joint improvements between DMARDs
Podcasts
Author Interview: Dr Jürgen Rech, 2024
Podcasts
Discussing PsA: Long-term safety of ixekizumab & bimekizumab treatment in a TNFi-IR population
Podcasts
Discussing RA: March 2024
Podcasts
Discussing AxSpA: Risk of Uveitis with Different bDMARDs & PROs following Secukinumab Treatment
Podcasts
Discussing RA: February 2024
Podcasts
Discussing PsA: Clinical Response to Guselkumab & Sequential Lines of b/tsDMARDs
Podcasts
Author Interview: Professor Andrea Rubbert-Roth, 2023
Podcasts
Discussing AxSpA: Bimekizumab in AxSpA & Secukinumab Patient Clustering
Podcasts
Discussing PsA: Impact of Biological Sex on Advanced Therapies & Upadacitinib-related Malignancies
Podcasts
AxSpA Podcast: Bimekizumab in AxSpA & Secukinumab Patient Clustering
Podcasts
Discussing AxSpA: Safety and Efficacy of Tofacitinib and Bimekizumab
Podcasts
Discussing PsA: Gender differences in treating PsA & safety of guselkumab in treating PsO and PsA
Podcasts
Discussing Rheumatology: November 2023
Podcasts
Discussing PsA: Bimekizumab in treating bDMARD-naïve PsA & upadacitinib in treating csDMARD and bDMARD IR PsA
Podcasts
CSF Author Interview: Dr. David Martin, 2023
Podcasts
AxSpA Podcast: Safety and Efficacy of Upadacitinib
Podcasts
Discussing Rheumatology: October 2023
Podcasts
EULAR Recommendations Podcast 2023 with Professor Peter Nash & Dr. Andreas Kerschbaumer
Podcasts
Author Interview: Professor Martin Bergman, 2023
Podcasts
Upadacitinib treating bDMARD-IR PsA & Post-marketing surveillance of tofacitinib treating PsA & RA
Podcasts
Discussing Rheumatology: September 2023
Podcasts
AxSpA Podcast: The Efficacy and Safety of Ixekizumab & Tildrakizumab
Podcasts
Author Interview: Sofia Ramiro
Podcasts
Discussing Rheumatology: August 2023
Podcasts
AxSpA Podcast: Tofacitinib, Golimumab, and Fatigue
Podcasts